{{Rsnum
|rsid=4987262
|Gene=PTGIR
|Chromosome=19
|position=46623592
|Orientation=minus
|GMAF=0.0101
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=PTGIR
}}{{PharmGKB
|RSID=rs4987262
|Name_s=R212C; PTGIR:Arg212Cys; polymorphism in exon II of the PTGIR gene on chromosome 19; rs4987262 C>T
|Gene_s=PTGIR
|Feature=
|Evidence=PubMed ID:18323528
|Annotation=Risk or phenotype-associated allele: T. Phenotype: The PTGIR R212C variant was associated with cardiovascular disease and events in a high cardiovascular risk cohort but not a low risk cohort. Study size: 980 (high risk, DHMC), 2293 (low risk, HPFS). Study population/ethnicity: Caucasians; DHMC, Dartmouth Hitchcock Medical Center; HPFS, Health Professional Follow-up Study. Significance metric(s): OR = 4.71, CI = 1.09-20.36; p = 0.022. Type of association: CO.
|Drugs=
|Drug Classes=
|Diseases=Cardiovascular Diseases
|Curation Level=Curated
|PharmGKB Accession ID=PA165292665
}}

{{on chip | 23andMe v3}}